Gyre Therapeutics, Inc.

GYRE

GYREGyre Therapeutics, Inc. US flag

NASDAQ Capital Market

5.69

USD

+0.13

- -

551.90MMarket Cap

Income Statement (CNY)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	90	102	113	106	117
+ Sales & Services Revenue	90	102	113	106	117
- Cost of Revenue	4	5	5	4	5
+ Cost of Goods & Services	4	5	5	4	5
Gross Profit	86	97	109	102	111
+ Other Operating Income	- -	- -	- -	- -	- -
- Operating Expenses	55	88	90	86	100
+ Selling, General & Admin	48	72	76	74	86
+ Research & Development	7	17	14	12	14
+ Other Operating Expense	- -	- -	- -	- -	- -
Operating Income (Loss)	30	9	19	16	11
- Non-Operating (Income) Loss	1	- -	96	-7	-3
+ Interest Expense, Net	- -	-1	-1	-2	-2
+ Interest Expense	- -	- -	- -	- -	- -
- Interest Income	- -	1	1	2	2
+ Other Non-Op (Income) Loss	1	- -	97	-5	-1
Pretax Income	30	9	-77	23	14
- Income Tax Expense (Benefit)	6	5	9	5	5
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	23	4	-85	18	10
- Net Extraordinary Losses (Gains)	- -	4	15	12	10
+ Discontinued Operations	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	4	15	12	10
Income (Loss) Incl. MI	23	- -	-100	6	- -
- Minority Interest	- -	-2	-7	-6	-5
Net Income, GAAP	23	2	-93	12	5
- Preferred Dividends	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	23	2	-93	12	5
EBIT	30	9	19	16	11
EBITDA	32	10	20	18	14
EBITDA Margin (%)	35.79	10.1	17.92	16.85	12.02
EBITA	30	9	19	16	11
Gross Margin (%)	95.51	95.31	95.91	96.33	95.35
Operating Margin (%)	33.64	9	16.94	15.35	9.86
Profit Margin (%)	26.16	2.25	-81.92	11.43	4.31
Sales per Employee	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -
Depreciation Expense	2	1	1	2	3
Basic Weighted Avg Shares	77	77	66	85	89
Basic EPS, GAAP	0.31	0.03	-1.41	0.14	0.06
Basic EPS from Cont Ops	0.31	0.06	-1.3	0.21	0.11
Diluted Weighted Avg Shares	77	77	66	102	103
Diluted EPS, GAAP	0.31	0.03	-1.41	0.12	0.05
Diluted EPS from Cont Ops	0.31	0.06	-1.3	0.17	0.1

Balance Sheet (CNY)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	45	50	57	65	102
+ Cash, Cash Equivalents & STI	26	36	34	27	52
+ Cash & Cash Equivalents	26	25	34	12	37
+ ST Investments	- -	11	- -	15	15
+ Accounts & Notes Receiv	13	17	17	29	37
+ Accounts Receivable, Net	10	16	15	20	31
+ Notes Receivable, Net	- -	2	- -	4	6
+ Loans Receivable, Net	- -	- -	- -	- -	- -
+ Other Receivable, Net	3	- -	1	5	- -
+ Inventories	6	6	4	6	10
+ Raw Materials	1	1	1	1	1
+ Work In Process	4	4	2	3	6
+ Finished Goods	1	1	1	3	3
+ Inventory Adjustments	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -
+ Other ST Assets	- -	-9	3	3	3
+ Misc ST Assets	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -
Total Noncurrent Assets	40	35	59	61	64
+ Property, Plant & Equip, Net	17	18	24	26	25
+ Property, Plant & Equip	21	22	28	31	32
- Accumulated Depreciation	3	4	4	6	8
+ LT Investments & Receivables	- -	7	23	25	24
+ LT Investments	- -	7	23	25	24
+ LT Receivables	- -	- -	- -	- -	- -
+ Other LT Assets	23	9	12	10	16
+ Total Intangible Assets	21	2	2	2	6
+ Goodwill	- -	- -	- -	- -	- -
+ Other Intangible Assets	21	2	2	2	6
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ Misc LT Assets	2	7	10	9	9
Total Assets	85	85	117	125	166
+ Payables & Accruals	10	11	19	13	18
+ Accounts Payable	- -	- -	- -	- -	- -
+ Accrued Taxes	2	2	5	3	3
+ Interest & Dividends Payable	- -	- -	- -	- -	- -
+ Other Payables & Accruals	7	9	14	10	14
+ ST Debt	- -	- -	- -	1	1
+ ST Borrowings	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	1	1
+ Other ST Liabilities	- -	1	1	6	- -
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	1	1	6	- -
Total Current Liabilities	10	12	20	20	18
+ LT Debt	1	- -	- -	1	- -
+ LT Borrowings	- -	- -	- -	- -	- -
+ LT Finance Leases	1	- -	- -	1	- -
+ Other LT Liabilities	1	- -	82	7	5
+ Accrued Liabilities	1	- -	- -	1	1
+ Pension Liabilities	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Misc LT Liabilities	- -	- -	82	6	4
Total Noncurrent Liabilities	2	- -	83	7	6
Total Liabilities	12	13	103	27	24
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -
+ Share Capital & APIC	10	33	68	136	172
+ Common Stock	10	- -	- -	- -	- -
+ Additional Paid in Capital	- -	33	68	136	172
- Treasury Stock	- -	- -	- -	- -	- -
+ Retained Earnings	23	7	-86	-73	-68
+ Other Equity	40	2	1	1	2
Equity Before Minority Interest	73	43	-16	63	106
+ Minority/Non Controlling Interest	- -	30	30	35	36
Total Equity	73	72	14	98	142
Total Liabilities & Equity	85	85	117	125	166
Shares Outstanding	77	77	77	86	91
Number of Employees	- -	- -	- -	- -	- -
Capital Leases - Total	1	1	- -	2	1
Net Debt	-26	-25	-34	-12	-37
Net Debt to Equity	-35.78	-34.86	-240.23	-12	-26.05
Tangible Common Equity Ratio	81.39	84.88	10.67	78.17	85.09
Current Ratio	4.36	4.06	2.85	3.32	5.6
Cash Conversion Cycle	- -	483.79	428.09	544.66	630.99

Cash Flow Statement (CNY)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	30	4	-85	18	10
+ Depreciation & Amortization	2	1	1	2	3
+ Non-Cash Items	-5	13	103	-7	4
+ Stock-Based Compensation	- -	13	7	1	7
+ Deferred Income Taxes	- -	-1	-1	-1	-1
+ Asset Impairment Charge	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	-5	- -	97	-7	-2
+ Chg in Non-Cash Work Cap	-5	-8	7	-16	-16
+ (Inc) Dec in Accts Receiv	-2	-8	1	-9	-12
+ (Inc) Dec in Inventories	-2	-1	2	-2	-4
+ (Inc) Dec in Prepaid Assets	-1	1	- -	1	- -
+ Inc (Dec) in Accts Payable	- -	- -	5	-4	1
+ Inc (Dec) in Other	- -	- -	-1	-1	-1
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Operating Activities	21	11	26	-4	1
+ Change in Fixed & Intang	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	1	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	1	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	-8	-5	-9	-3	-2
+ Acq of Fixed Prod Assets	-1	-5	-9	-2	-1
+ Acq of Intangible Assets	-7	- -	- -	-1	-1
+ Cash (Repurchase) of Equity	- -	- -	- -	1	24
+ Increase in Capital Stock	- -	- -	- -	1	24
+ Decrease in Capital Stock	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	-7	-16	-15	1
+ Dec in LT Investment	- -	- -	- -	- -	15
+ Inc in LT Investment	- -	-7	-16	-15	-14
+ Net Cash From Acq & Div	- -	-1	4	-2	- -
+ Cash from Divestitures	- -	- -	6	- -	- -
+ Cash for Acq of Subs	- -	-1	-2	-2	- -
+ Cash for JVs	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Investing Activities	-8	-14	-20	-20	- -
+ Dividends Paid	- -	- -	- -	- -	- -
+ Net Cash From Debt	-7	- -	- -	- -	- -
+ Cash From Debt	- -	- -	- -	- -	- -
+ Repayments of Debt	-7	- -	- -	- -	- -
+ Other Financing Activities	- -	- -	2	1	1
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Financing Activities	-7	- -	2	2	24
Effect of Foreign Exchange Rates	- -	-2	- -	- -	- -
Net Changes in Cash	6	-3	9	-21	25
EBITDA	32	10	20	18	14
EBITDA Margin (%)	35.79	10.1	17.92	16.85	12.02
Free Cash Flow	12	6	17	-7	-1
Net Cash Paid for Acquisitions	- -	1	-4	2	- -
Free Cash Flow to Firm	12	6	- -	-7	-1
Free Cash Flow to Equity	- -	5	18	-6	- -
Free Cash Flow per Basic Share	0.16	0.07	0.26	-0.08	-0.01
Price/Free Cash Flow	227.41	268.04	348.26	-17,616.61	1,737.3
Cash Flow to Net Income	0.89	4.64	-0.28	-0.3	0.2
Capital Expenditures	-8	-5	-9	-3	-2